Expression of phosphoprotein enriched in astrocytes 15 kDa (PEA-15) in astrocytic tumors: A novel approach of correlating malignancy grade and prognosis

Journal of Neuro-Oncology

Volumn 100, Issue 3, 2010, Pages 449-457

  Watanabe, Yosuke ^a   Yamasaki, Fumiyuki ^a   Kajiwara, Yoshinori ^a   Saito, Taiichi ^a   Nishimoto, Takeshi ^a   Bartholomeusz, Chandra ^b   Ueno, Naoto T ^b   Sugiyama, Kazuhiko ^a   Kurisu, Kaoru ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

Astrocytic tumor; Immunohistochemistry; Malignancy grade; Phosphoprotein enriched in astrocytes 15 kDa; Prognosis

Indexed keywords

KI 67 ANTIGEN; NIMUSTINE; PHOSPHOPROTEIN; PHOSPHOPROTEIN ENRICHED IN ASTROCYTES 15; TEMOZOLOMIDE; UNCLASSIFIED DRUG;

ADULT; AGE; AGED; ARTICLE; ASTROCYTOMA; BRAIN SURGERY; CANCER GRADING; CANCER RADIOTHERAPY; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; GENDER; GLIOBLASTOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PROGNOSIS; PROTEIN EXPRESSION;

ADULT; AGED; AGED, 80 AND OVER; ASTROCYTOMA; BRAIN NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; KI-67 ANTIGEN; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PHOSPHOPROTEINS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; STATISTICS AS TOPIC; STATISTICS, NONPARAMETRIC; YOUNG ADULT;

EID: 78449289861     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-010-0201-1     Document Type: Article

References (26)

1. NG Burnet AG Lynch SJ Jefferies, et al. 2007 High grade glioma: imaging combined with pathological grade defines management and predicts prognosis Radiother Oncol 85 371 378 10.1016/j.radonc.2007.10.008 18035440
2. LA Stewart 2002 Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trials Lancet 359 1011 1018 1:CAS:528:DC%2BD38XisV2htro%3D 10.1016/S0140-6736(02)08091- 1 11937180
3. C Daumas-Duport B Scheithauer J O'Fallon, et al. 1998 Grading of astrocytomas. A simple and reproducible method Cancer 62 2152 2165 10.1002/1097-0142(19881115)62:10<2152::AID-CNCR2820621015>3.0.CO;2-T
4. H Araujo N Danziger J Cordier, et al. 1993 Characterization of PEA-15, a major substrate for protein kinase C in astrocytes J Biol Chem 268 5911 5920 1:CAS:528:DyaK3sXktVGnt7c%3D 8449955
5. M Kubes J Cordier J Glowinski, et al. 1998 Endothelin induces a calcium-dependent phosphorylation of PEA-15 in intact astrocytes: identification of Ser104 and Ser116 phosphorylated, respectively, by protein kinase C and calcium/calmodulin kinase II in vitro J Neurochem 71 1307 1314 1:CAS:528:DyaK1cXls1Khtbk%3D 10.1046/j.1471-4159.1998.71031307.x 9721757
6. A Trencia A Perfetti A Cassese, et al. 2003 Protein kinase B/Akt binds and phosphorylates PED/PEA-15, stabilizing its antiapoptotic action Mol Cell Biol 23 4511 4521 1:CAS:528:DC%2BD3sXltVSit74%3D 10.1128/MCB.23.13.4511-4521. 2003 12808093
7. G Condorelli G Vigliotta A Cafieri, et al. 1999 PED/PEA-15: an anti-apoptotic molecule that regulates FAS/TNFR1-induced apoptosis Oncogene 18 4409 4415 1:CAS:528:DyaK1MXlsVOks7Y%3D 10.1038/sj.onc.1202831 10442631
8. D Kitsberg E Formstecher M Fauquet, et al. 1999 Knock-out of the neural death effector domain protein PEA-15 demonstrates that its expression protects astrocytes from TNFalpha-induced apoptosis J Neurosci 19 8244 8251 1:CAS:528:DyaK1MXmt1aqurc%3D 10493725
9. E Formstecher JW Ramos M Fauquet, et al. 2001 PEA-15 mediates cytoplasmic sequestration of ERK MAP kinase Dev Cell 1 239 250 1:CAS:528: DC%2BD3MXntVGrsLw%3D 10.1016/S1534-5807(01)00035-1 11702783
10. J Krueger FL Chou A Glading, et al. 2005 Phosphorylation of phosphoprotein enriched in astrocytes (PEA-15) regulates extracellular signal-regulated kinase-dependent transcription and cell proliferation Mol Biol Cell 16 3552 3561 1:CAS:528:DC%2BD2MXosVCgu7o%3D 10.1091/mbc.E04-11-1007 15917297
11. AW Whitehurst FL Robinson MS Moore, et al. 2004 The death effector domain protein PEA-15 prevents nuclear entry of ERK2 by inhibiting required interactions J Biol Chem 279 12840 12847 1:CAS:528:DC%2BD2cXitl2gtLY%3D 10.1074/jbc.M310031200 14707138
12. JY Fang BC Richardson 2005 The MAPK signalling pathways and colorectal cancer Lancet Oncol 6 322 327 1:CAS:528:DC%2BD2MXjs1Krsbk%3D 10.1016/S1470-2045(05)70168-6 15863380
13. G Vigliotta C Miele S Santopietro, et al. 2004 Overexpression of the ped/pea-15 gene causes diabetes by impairing glucose-stimulated insulin secretion in addition to insulin action Mol Cell Biol 24 5005 5015 1:CAS:528:DC%2BD2cXksVyhsbk%3D 10.1128/MCB.24.11.5005-5015.2004 15143191
14. C Zanca M Garofalo C Quintavalle, et al. 2008 PED is overexpressed and mediates TRAIL resistance in human non-small cell lung cancer J Cell Mol Med 12 2416 2426 1:CAS:528:DC%2BD1MXht1Whur8%3D 10.1111/j.1582-4934.2008.00283.x 18284607
15. M Garofalo G Romano C Quintavalle, et al. 2007 Selective inhibition of PED protein expression sensitizes B-cell chronic lymphocytic leukaemia cells to TRAIL-induced apoptosis Int J Cancer 120 1215 1222 1:CAS:528: DC%2BD2sXhvVOjuro%3D 10.1002/ijc.22495 17192900
16. M Todaro M Zerilli L Ricci-Vitiani, et al. 2006 Autocrine production of interleukin-4 and interleukin-10 is required for survival and growth of thyroid cancer cells Cancer Res 66 1491 1499 1:CAS:528:DC%2BD28XpsVegsQ%3D%3D 10.1158/0008-5472.CAN-05-2514 16452205
17. C Bartholomeusz D Rosen C Wei, et al. 2008 PEA-15 induces autophagy in human ovarian cancer cells and is associated with prolonged overall survival Cancer Res 68 9302 9310 1:CAS:528:DC%2BD1cXhtlOmt7rE 10.1158/0008-5472.CAN-08- 2592 19010903
18. A Glading JA Koziol J Krueger, et al. 2007 PEA-15 inhibits tumor cell invasion by binding to extracellular signal-regulated kinase 1/2 Cancer Res 67 1536 1544 1:CAS:528:DC%2BD2sXhvVWqsLw%3D 10.1158/0008-5472.CAN-06-1378 17308092
19. C Hao F Beguinot G Condorelli, et al. 2001 Induction and intracellular regulation of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) mediated apoptosis in human malignant glioma cells Cancer Res 61 1162 1170 1:CAS:528:DC%2BD3MXhsFSqs7k%3D 11221847
20. C Xiao BF Yang N Asadi, et al. 2002 Tumor necrosis factor-related apoptosis-inducing ligand-induced death-inducing signaling complex and its modulation by c-FLIP and PED/PEA-15 in glioma cells J Biol Chem 277 25020 25025 1:CAS:528:DC%2BD38XlsVWitLo%3D 10.1074/jbc.M202946200 11976344
21. A Eckert BC Bock KE Tagscherer, et al. 2008 The PEA-15/PED protein protects glioblastoma cells from glucose deprivation-induced apoptosis via the ERK/MAP kinase pathway Oncogene 27 1155 1166 1:CAS:528:DC%2BD1cXhvVymuro%3D 10.1038/sj.onc.1210732 17700518
22. F Renault-Mihara F Beuvon X Iturrioz, et al. 2006 Phosphoprotein enriched in astrocytes-15 kDa expression inhibits astrocyte migration by a protein kinase C delta-dependent mechanism Mol Biol Cell 17 5141 5152 1:CAS:528:DC%2BD28XhtlWqsLfN 10.1091/mbc.E05-11-1072 16987961
23. LP Petalidis A Oulas M Backlund, et al. 2008 Improved grading and survival prediction of human astrocytic brain tumors by artificial neural network analysis of gene expression microarray data Mol Cancer Ther 7 1013 1024 1:CAS:528:DC%2BD1cXlvFanurs%3D 10.1158/1535-7163.MCT-07-0177 18445660
24. C Lopez-Gines R Gil-Benso R Benito, et al. 2008 The activation of ERK1/2 MAP kinases in glioblastoma pathobiology and its relationship with EGFR amplification Neuropathology 28 507 515 10.1111/j.1440-1789.2008.00911.x 18410277
25. P Formisano G Perruolo S Libertini, et al. 2005 Raised expression of the antiapoptotic protein ped/pea-15 increases susceptibility to chemically induced skin tumor development Oncogene 24 7012 7021 1:CAS:528:DC%2BD2MXhtFCru7%2FK 10.1038/sj.onc.1208871 16044159
26. H Renganathan H Vaidyanathan A Knapinska, et al. 2005 Phosphorylation of PEA-15 switches its binding specificity from ERK/MAPK to FADD Biochem J 390 729 735 1:CAS:528:DC%2BD2MXpvFCju7o%3D 10.1042/BJ20050378 15916534